Universidad del País Vasco/Euskal Herriko Unibertsitatea-ko ikertzaileekin lankidetzan egindako argitalpenak (11)

2023

  1. Identification of germline cancer predisposition variants in pediatric sarcoma patients from somatic tumor testing

    Scientific Reports, Vol. 13, Núm. 1

2022

  1. Current status of precision medicine in pediatric oncology in Spain: a consensus report by the Spanish Society of Paediatric Haematology and Oncology (SEHOP)

    Clinical and Translational Oncology, Vol. 24, Núm. 5, pp. 809-815

  2. Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma

    New England Journal of Medicine, Vol. 386, Núm. 26, pp. 2471-2481

2021

  1. Clinical value of NGS genomic studies for clinical management of pediatric and young adult bone sarcomas

    Cancers, Vol. 13, Núm. 21

2020

  1. RNU6-1 in circulating exosomes differentiates GBM from non-neoplastic brain lesions and PCNSL but not from brain metastases

    Neuro-Oncology Advances, Vol. 2, Núm. 1

2018

  1. Variants in the 14q32 miRNA cluster are associated with osteosarcoma risk in the Spanish population

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Cytotoxic T lymphocyte-associated antigen 4 rs231775 polymorphism and osteosarcoma

    Neoplasma, Vol. 64, Núm. 2, pp. 299-304

  2. In-silico gene essentiality analysis of polyamine biosynthesis reveals APRT as a potential target in cancer

    Scientific Reports, Vol. 7, Núm. 1

  3. Strategies to design clinical studies to identify predictive biomarkers in cancer research

    Cancer Treatment Reviews, Vol. 53, pp. 79-97

2015

  1. Polymorphisms in miRNA processing genes and their role in osteosarcoma risk

    Pediatric Blood and Cancer, Vol. 62, Núm. 5, pp. 766-769

2014

  1. A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool

    Neuro-Oncology, Vol. 16, Núm. 4, pp. 520-527